UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number:0-20852 2000 Technology Parkway Newark, New York 14513 (Address of principal executive offices) (Zip Code) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number:0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or ot ...

Financial Data and Key Metrics - Consolidated revenues for Q1 2023 totaled $31.9 million, a 5.1% increase compared to $30.4 million in Q1 2022 [8] - Government defense sales increased by 24.7%, while commercial sales decreased by 1.7% compared to the same period last year [8] - Consolidated gross profit for Q1 2023 was $7.4 million, up 6.9% from the previous year, with a gross margin of 23.3% compared to 22.9% in Q1 2022 [10] - Operating profit was breakeven, inclusive of a $0.1 million one-time insurance deductible, compared to an operating loss of $0.3 million in Q1 2022 [11] - Net loss for Q1 2023 was $0.3 million or $0.02 per share, compared to a net loss of $0.2 million or $0.01 per share in Q1 2022 [12] - Adjusted EBITDA for Q1 2023 was $1.2 million or 3.6% of sales, compared to $1.1 million or 3.6% in Q1 2022 [12] Business Segment Performance - Battery & Energy Products segment revenues were $28.5 million, a 2.3% decrease compared to $29.2 million in Q1 2022 [8] - Medical and government defense businesses within this segment declined by 8.5% and 4.7%, respectively, partially offset by a 21.3% increase in oil and gas market sales [8] - Gross margin for this segment was 22.9%, a sequential increase of 130 basis points from Q4 2022 [10] - Communications Systems segment revenues were $3.4 million, a 181.8% increase compared to $1.2 million in Q1 2022 [9] - Gross margin for this segment was 26.8%, up from 19.4% in Q1 2022 [11] Market and Backlog Data - Total backlog at the end of Q1 2023 was $108.1 million, with $96.1 million due to ship over the remaining 9 months of 2023, representing a 30.2% increase compared to $73.8 million in the same period last year [8] - Battery & Energy Products backlog was $87.9 million, virtually identical to the $88.6 million backlog at the end of Q4 2022 [9] - Communications Systems backlog was $20.2 million, down 9.8% from $22.4 million at the end of Q4 2022 [9] Strategic Direction and Industry Competition - The company is focused on executing its backlog and improving gross margins, with initiatives such as price realization activities, extending the sales and operations planning process, and improving new product launches [14][15] - On the Battery & Energy side, the company is developing products for medical wearables, IoT, and utility monitoring applications, with new products expected to launch in 2023 [16][17][18] - On the Communications Systems side, the company is working on advanced amplification and power products for military applications and is close to initial commercial orders for its EL8000 server case and power system [19] - The company is also exploring opportunities in electrification and 5G markets, leveraging its cell design expertise and power system capabilities [19] Management Commentary on Operating Environment and Outlook - The company faced operational inefficiencies in Q1 due to a cybersecurity attack, which delayed production and impacted the ability to take full advantage of the backlog [4][5] - Despite the challenges, the company saw improvement in gross margins and remains focused on returning to profitable growth [14][20] - Supply chain issues persist, particularly with specialty parts, but there are signs of improvement in component lead times and part availability [14] Other Important Information - The cybersecurity attack resulted in a $100,000 insurance deductible, which was recognized in operating expenses [7] - Inventory increased by $6.1 million or 14.9% over Q4 2022, with $5.1 million of the increase occurring at the Newark and Virginia Beach locations [12] - The company ended Q1 2023 with working capital of $52.5 million and a current ratio of 2.8 [13] Q&A Session Summary - No specific questions were asked during the Q&A session, and the call concluded with closing remarks from the CEO [20][21][22]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other ...

Ultralife Corporation (NASDAQ:ULBI) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Josh Sullivan - Benchmark Company John Deysher - Pinnacle Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Fourth Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be ...

Ultralife Corporation (NASDAQ:ULBI) Q3 2022 Earnings Conference Call October 27, 2022 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Popielec - President and Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company, LLC Operator Hello and welcome to Ultralife Corporation Third Quarter 2022 Earnings Release. My name is Pricilla and I will be your coordinator for today's event. Please note this call is being r ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation of 16-1387013 (I.R.S. Employer Identification No.) (315) 332-7100 (Registrant's telephone number, including area code:) 14 ...

Ultralife Corporation. (NASDAQ:ULBI) Q2 2022 Earnings Conference Call July 28, 2022 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Popielec - President and Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Operator Good day, and welcome to this Ultralife Corporation Second Quarter 2022 Earnings Release Conference Call. At this time, for opening remarks and introductions, I would like to turn the call over to Miss. Jody Burfening. Please g ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission file number: 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or ot ...

Ultralife Corporation (NASDAQ:ULBI) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Jody Burfening - Investor Relations Mike Popielec - President and Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company Operator Good day, and welcome to this Ultralife Corporation First Quarter 2022 Earnings Release Conference Call. At this time, for opening remarks and introductions, I'd like to turn the call over to Ms ...